{"id":41028,"name":"Medical Report 0401A – 117/01/19","slug":"medical-report-0401-a-117-01-19","facts":{"mass":1,"volume":0.1,"base_price":30,"portion_size":1},"group":{"id":280,"name":"General"},"bonuses":{"misc":[],"role":[],"skills":[]},"category":{"id":17,"name":"Commodity"},"icon_url":"https://images.evetech.net/types/41028/icon?size=64","materials":[],"published":false,"sde_build":3503375,"attributes":[],"meta_group":null,"variations":[],"description":" DB AUTH 90104\n SECURE ACCESS POINT BRAVO\n PERSONNEL BLOCK – SUB LEVEL 12 – ROOM A113\n\nENTRY CLEARED\n\nSubject shows no further signs of motion sickness or neural download corruption after ten seconds consciousness. Cognitive function reaches 99.7% within five seconds of awakening, spatial awareness confirmed with halo response test after five seconds of consciousness. \n\nTreatment H22a appears to have resolved prior issues with lapse of cognitive function after neural re-alignment from quantum data transfer. Vital signs appear normal.\n\nGiven initial testing, will recommend to command that testing is expanded to whole of first subset, and subsequent batches of clones. \n\nCurrently awaiting approval from 6NJ for phase three testing. Kosakami and Laitanen seem preoccupied, may have to consult General Abraxas. \n\nReport Ends.","market_path":[{"id":19,"name":"Trade Goods"},{"id":20,"name":"Industrial Goods"}],"produced_by":[]}